Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Drinabant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Opiant Announces Notice of Allowance for U.S. Patent Covering OPNT004
    Opiant Announces Notice of Allowance for U.S. Patent Covering OPNT004

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502509/0/en/Opiant-Pharmaceuticals-Announces-Notice-of-Allowance-for-U-S-Patent-with-Claims-Covering-OPNT004-for-the-Treatment-of-Cannabinoid-Hyperemesis-Syndrome.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    IRISYS Awarded $850,000 NIH Contract for the Formulation of Drinaban
    IRISYS Awarded $850,000 NIH Contract for the Formulation of Drinaban

    11 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/irisys-awarded-850-000-nih-contract-for-the-formulation-of-drinabant-a-drug-in-development-for-treatment-of-acute-cannabinoid-overdose-301203462.html

    PRNEWSWIRE
    11 Jan 2021
    Share Share